The share price is up nearly 1.5% on the back of two positive analyses published today.

Stifel reaffirms its 'buy' recommendation on Assystem and raises its target price from 50 to 55 euros, following the engineering consultancy's announcement of first-quarter 2023 sales 9% ahead of expectations.

'Also, taking this into account, we are slightly raising our forecasts for 2023. In addition, we are increasing EPS by 6.6% to also take into account a higher contribution from the results of Expleo, 38%-owned by Assystem', says the broker.

Invest Securities confirms its buy rating on Assystem shares, with a price target raised from €54 to €55.

The analyst believes that the 16.4% rise in 1st-quarter sales illustrates the message conveyed by management in mid-March on the occasion of the 2022 results, namely that 'the acceleration in growth would be faster than initially envisaged'.

Given that the main bottleneck, recruitment, is also being managed fairly well (25% of recruitment planned for 2023 was completed in Q1), momentum is indeed improving in consolidated activities", the research house points out.

Invest Securities now believes that 'the only uncertainty lies in the timing of the disposal of the Expleo and Framatome stakes', but stresses that 'more than ever, Assystem remains a strong conviction to take advantage of the nuclear revival'.

Copyright (c) 2023 CercleFinance.com. All rights reserved.